Improvements in life expectancy in adult type 2 diabetes patients in the last six decades
- PMID: 21489648
- DOI: 10.1016/j.diabres.2011.03.022
Improvements in life expectancy in adult type 2 diabetes patients in the last six decades
Abstract
Aim: To investigate the historical changes in survival with diabetes in adult type 2 diabetes patients.
Methods: We analyzed 9066 deaths, 54.2% males, registered at "I. Pavel" Bucharest Diabetes Centre, aged 40-64 years and deceased between 1943 and 2009. We split the analysis in three time periods according to year of death: 1943-1965, 1966-1988 and 1989-2009.
Results: The mean age at diabetes onset was 55.5 ± 6.2 years, with mean disease duration at death 12.7 ± 8.2 years and mean age at death 68.2 ± 8.7 years. The mean disease duration at death was 9.9 ± 7.3 years in 1943-1965 period, followed by a significant (p<0.001) rise to 12.2 ± 8.2 years in 1966-1988, and 14 ± 8.1 years (p < 0.001) in 1989-2009. There was a significant increase for coronary heart diseases and cancer and a significant decrease for infections and end-stage renal disease as causes of death.
Conclusion: We found a significant increase in age at onset and survival with diabetes leading to a significant increase in age at death.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Improvements in life expectancy in type 1 diabetes patients in the last six decades.Diabetes Res Clin Pract. 2009 Nov;86(2):146-51. doi: 10.1016/j.diabres.2009.08.012. Epub 2009 Sep 23. Diabetes Res Clin Pract. 2009. PMID: 19783316
-
The dynamics of life expectancy over the last six decades in elderly people with diabetes.Diabetes Res Clin Pract. 2013 Feb;99(2):217-22. doi: 10.1016/j.diabres.2012.10.020. Epub 2012 Nov 30. Diabetes Res Clin Pract. 2013. PMID: 23206671
-
Mortality trends in noninsulin-treated type 2 diabetes mellitus patients in the 1943-2000 period.Rom J Intern Med. 2007;45(4):371-7. Rom J Intern Med. 2007. PMID: 18767413
-
Epidemiology of type 2 diabetes in Mexico.Arch Med Res. 2005 May-Jun;36(3):188-96. doi: 10.1016/j.arcmed.2005.01.006. Arch Med Res. 2005. PMID: 15925009 Review.
-
There really is an epidemic of type 2 diabetes.Diabetologia. 2005 Aug;48(8):1459-63. doi: 10.1007/s00125-005-1843-y. Epub 2005 Jul 9. Diabetologia. 2005. PMID: 16007413 Review. No abstract available.
Cited by
-
Cancer specific mortality in insulin-treated type 2 diabetes patients.PLoS One. 2014 Mar 25;9(3):e93132. doi: 10.1371/journal.pone.0093132. eCollection 2014. PLoS One. 2014. PMID: 24667573 Free PMC article.
-
Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine.J Diabetes Res. 2015;2015:962346. doi: 10.1155/2015/962346. Epub 2015 Jun 14. J Diabetes Res. 2015. PMID: 26176017 Free PMC article.
-
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1037-1045. doi: 10.1016/j.bbadis.2016.04.017. Epub 2016 May 6. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27156888 Free PMC article. Review.
-
PATIENTS TREATED WITH INSULIN AND SULPHONYLUREA ARE AT INCREASED MORTALITY RISK AS COMPARED WITH THOSE TREATED WITH INSULIN PLUS METFORMIN.Acta Endocrinol (Buchar). 2017 Jul-Sep;13(3):329-333. doi: 10.4183/aeb.2017.329. Acta Endocrinol (Buchar). 2017. PMID: 31149195 Free PMC article.
-
Effect of type 2 diabetes medications on fracture risk.Ann Transl Med. 2019 Oct;7(20):580. doi: 10.21037/atm.2019.09.51. Ann Transl Med. 2019. PMID: 31807561 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical